Back
NLS Pharmaceutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
NLSP
NLS Pharmaceutics
Last Price:
$1.59
Seasonality Move:
-24.38%
7 Day Trial
ALL ACCESS PASS
$
7

Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight buying pressure.
NLS Pharmaceutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.6 | Sell |
20-day SMA: | 1.87 | Sell |
50-day SMA: | 1.99 | Sell |
200-day SMA: | 4.63 | Sell |
8-day EMA: | 1.64 | Sell |
20-day EMA: | 1.78 | Sell |
50-day EMA: | 2.08 | Sell |
200-day EMA: | 5.56 | Sell |
NLS Pharmaceutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 38.37 | Sell |
Chaikin Money Flow: | 6519 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.62 - 2.22) | Sell |
Bollinger Bands (100): | (1.66 - 3.64) | Sell |
NLS Pharmaceutics Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NLS Pharmaceutics Stock
Is NLS Pharmaceutics Stock a Buy?
-
NLS Pharmaceutics share price is 1.58 while NLSP 8-day simple moving average is 1.60, which is a Sell signal.
-
The stock price of NLSP is 1.58 while NLS Pharmaceutics 20-day SMA is 1.87, which makes it a Sell.
-
NLS Pharmaceutics 50-day simple moving average is 1.99 while NLSP share price is 1.58, making it a Sell technically.
-
NLSP stock price is 1.58 and NLS Pharmaceutics 200-day simple moving average is 4.63, creating a Sell signal.
NLSP Technical Analysis vs Fundamental Analysis
Sell
40
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy or a Sell?
-
NLS Pharmaceutics stock is rated a SellThe current NLS Pharmaceutics [NLSP] share price is $1.58. The Score for NLSP is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
NLS Pharmaceutics Stock Info
Market Cap:
6M
Price in USD:
1.58
Share Volume:
15.2K
NLS Pharmaceutics 52-Week Range
52-Week High:
18.39
52-Week Low:
1.47
Sell
40
NLS Pharmaceutics (NLSP)
is a Sell
NLS Pharmaceutics Share Price Forecast
-
What is the NLS Pharmaceutics stock price today?The NLS Pharmaceutics stock price is 1.58 USD today.
-
Will NLSP stock go up or go down?NLS Pharmaceutics> share price is forecast to RISE/FALL based on technical indicators
-
Is NLS Pharmaceutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NLS Pharmaceutics is overvalued.
Is NLS Pharmaceutics Stock a Buy?
-
NLS Pharmaceutics share price is 1.58 while NLSP 8-day exponential moving average is 1.64, which is a Sell signal.
-
The stock price of NLSP is 1.58 while NLS Pharmaceutics 20-day EMA is 1.78, which makes it a Sell.
-
NLS Pharmaceutics 50-day exponential moving average is 2.08 while NLSP share price is 1.58, making it a Sell technically.
-
NLSP stock price is 1.58 and NLS Pharmaceutics 200-day simple moving average is 5.56, creating a Sell signal.
Technical Analysis of NLS Pharmaceutics
Should I short NLS Pharmaceutics stock?
-
NLSP Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting NLS Pharmaceutics is a Sell
-
NLS Pharmaceutics Relative Strength Index (RSI) is 38.37, which suggest NLS Pharmaceutics is oversold
-
The Bollinger Bands (25) for NLS Pharmaceutics is (1.62 - 2.22), which suggest NLS Pharmaceutics is a Sell
-
The Bollinger Bands (100) for NLS Pharmaceutics is (1.66 - 3.64), which suggest NLS Pharmaceutics is a Sell
* NLS Pharmaceutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.